The eyes were examined weekly for the first 3 weeks after surgery and at monthly intervals for the remainder of the 5-month observation period. All examiners were masked to the treatment group assignment of each animal. The effects of the PRK treatment regimen were assessed by corneal topography, cycloplegic retinoscopy, A-scan ultrasonography, slit lamp biomicroscopy, and applanation tonometry. To make these measurements, the animals were anesthetized with intramuscular injections of ketamine hydrochloride (15 mg/kg body weight) and acepromazine maleate (0.2 mg/kg body weight), and their eyelids were held open with lid retractors. Cycloplegia was induced with 3 drops of topically instilled 0.5% tropicamide 10 minutes apart, 45 minutes before performing the retinoscopy. Retinoscopy was performed by three examiners, and the results were expressed as mean spherical equivalent, spectacle plane refractive corrections. During these measurements, pupil size and the retinoscopy reflex were stable. There was no evidence of residual accommodation. Corneal refractive power was measured with a handheld corneal topographer (Vista; EyeSys, Houston, TX). The depth of the vitreous chamber was measured with A-scan ultrasonography at a velocity of 1532 m/s. The reported values represent the mean of 10 individual measurements. To be acceptable, the standard error for the 10 measurements had to be less than 8 μm (AXIS-II; Quantel Medical Inc., Clermont-Ferrand, France). Intraocular pressure was measured by a noncontact tonometer (XPERT NCT Plus Advanced Logic Tonometer; Reichert Ophthalmic Instruments, Depew, NY). The reported values represent the means of three individual measures.